Bioventus (BVS) Q2 2026 Earnings Call Transcript
· finance.yahoo.com
Pain Treatments surged 11.5% as management explores strategic alternatives.
Although the company may voluntarily do so from time to time, it undertakes no commitment to update or revise the forward-looking statements, whether as a resul...